Updated Jul 16, 2026 · Last SEC filing 2026-06-15
Century Therapeutics, Inc. (IPSC) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 4 Form 8-K material event filings were reported by IPSC in the last 90 days. 2 Form 144 notices of proposed sale were filed for IPSC stock. InsiderAlpha tracks every IPSC SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001850119 |
|---|
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-06-15 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carr Douglas | SVP Finance & Operations | S — Open-market sale | 1.7K | $2.23 | $4K | SEC | |
| Russotti Gregory | See Remarks | S — Open-market sale | 2.6K | $2.23 | $6K | SEC | |
| Cowan Chad | Chief Scientific Officer | F — Tax withholding / forfeiture | 358 | $2.24 | $802 | SEC | |
| Pfeiffenberger Brent | President and CEO | F — Tax withholding / forfeiture | 13.8K | $2.24 | $31K | SEC | |
| Carr Douglas | SVP Finance & Operations | S — Open-market sale | 249 | $2.11 | $526 | SEC | |
| Russotti Gregory | See Remarks | S — Open-market sale | 524 | $2.11 | $1K | SEC | |
| Pfeiffenberger Brent | President and CEO | F — Tax withholding / forfeiture | 463 | $2.13 | $986 | SEC | |
| Pfeiffenberger Brent | President and CEO | F — Tax withholding / forfeiture | 31.2K | $2.34 | $73K | SEC | |
| Carr Douglas | SVP Finance & Operations | S — Open-market sale | 264 | $2.34 | $618 | SEC | |
| Cowan Chad | Chief Scientific Officer | F — Tax withholding / forfeiture | 1.4K | $2.19 | $3K | SEC | |
| Carr Douglas | SVP Finance & Operations | S — Open-market sale | 7.0K | $2.55 | $18K | SEC | |
| Russotti Gregory | See Remarks | S — Open-market sale | 10.1K | $2.55 | $26K | SEC | |
| Cowan Chad | Chief Scientific Officer | F — Tax withholding / forfeiture | 1.4K | $2.73 | $4K | SEC | |
| Pfeiffenberger Brent | President and CEO | F — Tax withholding / forfeiture | 55.4K | $2.73 | $151K | SEC | |
| Russotti Gregory | See Remarks | S — Open-market sale | 479 | $2.54 | $1K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Century Therapeutics, Inc. (IPSC). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Pfeiffenberger Brent | 3 | $105K |
| Carr Douglas | 3 | $5K |
| Russotti Gregory | 2 | $7K |
| Riva Alessandro | 1 | — |
| Quimi Daphne | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in IPSC insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live IPSC dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.